Video 1 Description
Are you a healthcare professional?
This site is intended only for Healthcare Professionals who are interested in the management of gastric cancer and/or gastro-oesophageal junction cancers.
I AM NOT A HEALTHCARE PROFESSIONAL BUT WOULD LIKE MORE INFORMATION ON GASTRIC/GASTRO-OESOPHAGEAL JUNCTION CANCERSPeer perspectives
Hear from some of the world’s leading pathologists discussing how to test, interpret, and report CLDN18.2 expression.
What Is CLDN18.2?
Matteo Fassan, MD, PhD
How to Prepare Samples for CLDN18.2 Testing
Takeshi Kuwata, MD, PhD
How to Test for CLDN18.2
Christoph Röcken, MD
How to Interpret CLDN18.2
Josef H. Rüschoff, MD
How to Report CLDN18.2
Kristina A. Matkowskyj, MD, PhD
CLDN18.2 Expert Committee
The experts above have been contracted as paid advisors through Astellas Pharma Inc. and have received compensation for their time.
The content on this website has been created by Astellas Pharma Inc. and may or may not reflect the views of the experts shown above unless explicitly specified.
CLDN18.2, claudin 18 isoform 2; G/GEJ, gastric/gastroesophageal junction.
Review whole slide images and test your interpretation skills
Contact us if you’d like to know more
We are more than happy to support you in case you have questions. Feel free to reach out via e-mail.
